baber/WOPTO huggingface dataset:
Patent DK-209483-D0 (DK)
Inventor: FISCHER HUGO
IPC: C04B28/14
Filed: 1983-05-11
Abstract: 1. A panel wall in which two encased structural panels (2) are disposed so that they abut one another along a longitudinal side, the rear longitudinal edges (7) being adjacent one another and the rear flat side (6) having a longitudinal edge strip adjacent and secured to a girder (1), each structural panel (2) in the abutting region forming an arcuate, encased (3) transition (4) over the entire thickness of the panel from the front flat side (5) to the rear longitudinal edge (7), the resulting joint (8), which in cross-section has a curved funnel shape, being trowelled off with a filling compound (9) but leaving a reinforcing strip, characterised in that the filling compound (9) is made from a mixture of plaster (calcium sulphate hemihydrate), limestone meal, mica, dispersion powder, sulphate accelerator, cellulose derivative, keratin retarder and wetting agent at a preset mixing-water/solid ratio and the transition (4) from the front flat side (5) to the rear longitudinal edge (7) forms a quarter-circle and the mixture from which the filling compound (9) is produced contains 70-95% alpha-gypsum and, apart from additives such as polyvinyl alcohol, asbestos and bentonite is adjusted to a mixing-water/solid ratio of not more than 0.5.
Patent DK-313588-D0 (DK)
Inventor: CLARK DAVID ALAN
IPC: C07D263/38
Filed: 1988-06-09
Abstract: Oxazolidin-2-one derivs. of formula (I), corresp. pharmaceutically-acceptable acid addn. salt or pharmaceutically-acceptable cationic salt are new. Rb is (i), (ii) (iii) or (iv), W is S or O; X, X' is H, Cl, F or CF3; Y is -COOR1, -CON(R1)CH2CONR3R3, gp. (v) or vi), Ra, R1, R2, R3 are H, CH3, R4 is CH3 or CF3. For pharmaceutically-acceptable acid addn. salt, Y is gp. (v) or Rb is gp. (iii). For pharmaceutically-acceptable cationic salt y is -COOH or gp. (vi). - Also claimed is an optically active cpd. of formula (I) and use of cpd. (I) as a medicament for the treatment of hyperglycemia.
Patent DK-342883-D0 (DK)
Inventor: REGNIER GILBERT
IPC: C07D473/12
Filed: 1983-07-27
Abstract: New xanthine compounds of the formula:   <IMAGE>   in which: R1 is hydrogen or alkyl from C1 to C5 inclusive; R2 is a hydrocarbon radical up to C6 having optionally a double bond, phenyl or benzyl; R3 is hydrogen, alkyl, hydroxyalkyl or dihydroxyalkyl each from C1 to C5 R4 represents:   <IMAGE>   in which: Y is hydrogen, halogen, alkyl or alkoxy from C1 to C5 or hydroxyl; Z is methylene or a straight or branched hydrocarbon radical from C2 to C5 optionally substituted by hydroxyl; and A is an amino group of the formula:   <IMAGE>   p being 2 or 3;   <IMAGE>   in which q is 1 or 2, and X is a single bond, oxygen or   <IMAGE>   in which R5 is hydrogen, alkyl or alkylene up to C5, or   <IMAGE>   in which m is an integer from 2 to 6 and R6 is alkyl from C1 to C5. These new compounds and physiologically tolerable acid addition salts thereof may be used as medicines especially in the treatment of all diseases where it is necessary to inhibit the antigenic antibody reactions.
Patent DK-492186-D0 (DK)
Inventor: ZWICKER EBERHARD
IPC: H04R25/00
Filed: 1986-10-15
Abstract: 1. A hearing aid, for people with damaged hearing, with a sound pick-up microphone arrangement and earphone between which is connected an arrangement of several voice frequency selecting channels (4 to 9), in which there is provided in each individual voice frequency selecting channel a device (16) for measuring the strength of a signal and a summing element (29) having a positive and at least one negative input, the positive input of the summing element being coupled to the output of the same-channel and the negative input of the summing element being coupled with the output of a measuring device (16) in the adjacent channel, with the differential signal given off by the summing element (29) influencing the amplification in the same channel voice frequency selecting channel.
Patent DK-554689-D0 (DK)
Inventor: BECHTOLD HERBERT
IPC: A61M5/20
Filed: 1989-11-07
Abstract: PCT No. PCT/EP88/00375 Sec. 371 Date Nov. 3, 1989 Sec. 102(e) Date Nov. 3, 1989 PCT Filed May 5, 1988 PCT Pub. No. WO88/08725 PCT Pub. Date Nov. 17, 1988.The injection device described comprises a loading element (74) which can be moved longitudinally for loading purposes and is rotatable for the purpose of setting the injection dose. Associated with this loading element (74) is a second setting element (86). The latter allows a judicious internal combination of the information supplied by the position of the loading element (74) and of the second setting element (86). The patient can effect several individually-dosed injections from a single container.
Patent DK-556489-D0 (DK)
Inventor: EISELE WOLFGANG
IPC: C08L33/06
Filed: 1989-11-08
Abstract: The present invention relates to thermosetting aqueous synthetic resin mixtures for coating wooden materials based on etherified melamine/formaldehyde condensation products and aqueous synthetic resin dispersions, and to a process for preparing these mixtures and the use for coating wooden materials.
Patent DK-664488-D0 (DK)
Inventor: AKKERBOOM PIET JOHANNES
IPC: A61K9/20
Filed: 1988-11-29
Abstract: A multi-purpose pharmaceutical tablet which can either be readily swallowed or dissolved in water to give a dispersion, comprises a tetracycline, either microcrystalline cellulose or microfine cellulose, low-substituted hydroxypropylcellulose and a thickening agent, which is preferably hydroxypropyl methylcellulose, and optionally other usual adjuvants. The tablet may be easily swallowed as such, but when immersed in water, it affords a very fine dispersion within 30-60 seconds. The tablet may be prepared by direct compression, or by a wet granulation process in which a granulate is used containing the tetracycline and either microcrystalline cellulose or microfine cellulose, but without a substantial amount of a wet binding substance.
Patent HU-913293-D0 (HU)
Title: Process for the production of pierazine derivatives and medical preparations containing them
Inventor: CLIFFE IAN ANTHONY
IPC: C07D333/24
Filed: 1991-10-18
Abstract: Piperazine derivative of formula <CHEM> and the pharmaceutically acceptable acid addition salts, where A is an alkylene chain of 1 or 2 carbon atoms optionally substituted by one or more lower alkyl groups, m is 0, 1 or 2, R is hydrogen or lower alkyl, R<1> is aryl or a mono- or bicyclic heteroaryl radical, R<2> is hydrogen or lower alkyl, R<3> is a heteroaryl radical, R<4> is hydrogen, lower alkyl or aryl, and R<5> is hydrogen, lower alkyl, cycloalkyl, cycloalkyl(lower)alkyl, aryl, or aryl(lower)alkyl or R<4> and R<5> together with the nitrogen atom to which they are both attached represent a saturated heterocyclic ring which may contain a further hetero atom are 5-HT1A- binding agents and may be used, for example, as anxiolytics.
Patent HU-895457-D0 (HU)
Title: Process for producing 3beta, 17beta-hydroxy-substituted steroid derivatives and pharmaceutical compositions comprising same as active ingredient
Inventor: JOHNSTON JOHN O'NEAL
IPC: A61K31/565
Filed: 1989-10-26
Abstract: The present invention is directed to a group of compounds which are 3 beta ,17 beta -hydroxy steroids, and related steroidal structures. These compounds are aromatase inhibitors, and thus, regulate or inhibit the conversion of androgens to estrogens. These compounds may be utilized to treat conditions potentiated by the presence of estrogens. These compounds exhibit a slower onset of action and a longer half life relative to the 10-(2-alkynyl) steroidal aromatase inhibitors disclosed in U.S. Patent 4,322,416.
Patent NO-863682-D0 (NO)
Inventor: HIDASI GYOERGY
IPC: C07B57/00
Filed: 1986-09-15
Abstract: PCT No. PCT/HU86/00004 Sec. 371 Date Oct. 15, 1986 Sec. 102(e) Date Oct. 15, 1986 PCT Filed Jan. 16, 1986 PCT Pub. No. WO86/04216 PCT Pub. Date Jul. 31, 1986.According to the present invention there is provided a synergistic insecticidal composition containing more than one active ingredients and being harmless to environment characterized by comprising in an amount of from 0.001 to 99% by weight a synthetic pyrethroid of the Formula /I/   <IMAGE> (I) namely substantially only the 1RtransS and 1StransR entantiomer-pair /Ib/ out from the possible eight isomers-optionally in admixture with an amount of up to 100% by weight of one or more activator/s/ and auxiliary agent/s/, particularly antioxidants, stabilizing agents, wetting agents, emulsifying agents, dispersing agents, antifoam agents, dileunts and/or fillers. The enantiomer-pair Ib consisting of the 1RtransS and 1StransR isomers is new and the invention also relates to the said new enantiomer-pair and a process for the preparation thereof. The advantage of the insecticidal composition of the present invention is that it is less toxical towards warm-blooded animals and useful parasites and is therefore much less harmful to the environment.
Patent NO-870430-D0 (NO)
Inventor: PALM MICHIEL
IPC: H02H9/06
Filed: 1987-02-03
Abstract: Device for establishing such a galvanic connection between conductors of a first batch and conductors of a second batch that on the one hand signal transmission between the two batches can take place undisturbed, and on the other hand transmission consequent on inducing electro-magnetic radiation will be blocked in two respects. High voltage induced in the conductors of the first batch consequent on high-energetic radiation, which manifests itself as a pulse, is reduced in stages to a relatively low residual voltage on the conductors of the second batch. Besides voltages induced either in the conductors of the first batch or in the conductors of the second batch, consequent on electromagnetic radiation having a signal character, are strongly reduced, in such a way that the conductors of the relevant other batch (either the second or the first) will not cause a detectable corresponding radiation. For that purpose an LD-filter configuration with one or two T-sections connected in cascade has been connected between each pair of corresponding conductors. In one of these T-sections a coil, which also forms part of a high- voltage reducing section, has been utilized. The device is mounted in a housing, which blocks electromagnetic radiation and can be fixed to a wall of a Faraday cage room in such a way that an opening in that wall will be closed. In this manner electric conductors extending to the interior of the Faraday cage room can be connected, in the desired way, to electric conductors establishing a connection with the outer world.
Patent NO-892970-D0 (NO)
Inventor: RIVIER JEAN EDOUARD FREDERIC
IPC: A61P5/00
Filed: 1989-07-20
Abstract: Synthetic peptides which stimulate the release of pituitary GH in animals, including humans, and are more resistant to enzymatic degradation in the body than hGRF having the sequence: (B)R1-R2-R3-Ala-Ile-Phe-Thr-R8-Ser- THETA 10-Arg-R12-R13-Leu-R15-Gln-Leu-R18-Ala-A rg-R21-R22-Leu-R24-R @5-Ile-R27-R28-R @9-Gln-Gln-Gly-Glu-R34-Asn-Gln-Glu-R38-R39-R40-Arg-R42-R43-R44 wherein R1 is Tyr, D-Tyr, Met, D-Met, Phe, D-Phe, pCl-Phe, Leu, His or D-His; B is H, C<a>Me, N<a>Me, desamino, Ac or For; R2 is Ala, D-Ala, NMA or D-NMA; R3 is Asp or D-Asp; R8 is Ser, Asn, Lys, Arg, Asp or Gln; R10 is Tyr, D-Tyr or Phe; R12 is Arg or Lys; R13 is Ile, Val, Leu or Ala; R15 is Gly, Ala or  beta -Ala; R18 is Ser or Tyr; R21 is Lys, D-Lys, Arg or D-Arg; R22 is Leu, Ile, Ala or Val; R24 is Gln or His; R25 is cys, abu, asp, glu, orn, lys, dab or dap; R27 is Met, D-Met, Ala, Nle, Ile, Leu, Nva or Val; R28 is Asn or Ser; R29 is cys, abu, asp, glu, orn, lys, dab or dap; R34 is Ser or Arg; R38 is Arg or Gln; R39 is Gly or Arg; R40 is Ala or Ser; R42 is Phe or Ala; R43 is Asn or Arg; R44 is a natural amino acid, such as Leu or Val. C-terminal sequences of from 1 to 15 residues beginning at R44 and extending as far as up to R29 may be deleted. These peptides as well as their nontoxic salts may also be used diagnostically.
Patent NO-894910-D0 (NO)
Inventor: HINTERMAYER JOCHEN
IPC: C04B35/58
Filed: 1989-12-07
Abstract: The present invention provides a process for the production of silicon nitride by the reaction of silicon and nitrogen, wherein, in one reaction step, silicon powder is reacted with nitrogen which continuously rotates at a temperature of from 1000 DEG  to 1800 DEG C. and at a pressure of from 1.01 to 1.8 bar up to a nitrogen content of 1 to 39.5% by weight. The present invention also provides a silicon nitride produced by this process wherein it is obtained in porous form and has the following properties. a) grain size of 0.1 to 20 mm. b) nitrogen content of 1 to 39.5% by weight, c) oxygen content of 1%, d) ratio of  alpha : beta -phase of 1:9 to 9:1.
Patent NO-895080-D0 (NO)
Inventor: VINGHOEG GEIR
IPC: F41A23/14
Filed: 1989-12-15
Abstract: Tripod for firearms, comprising a pivot support (1) having a vertical axis, to the flanges (5, 6, 7) of which are secured telescopical, adjustable legs (2, 3, 4), the first flange axis being horizontal enabling the leg (5) to be turned a vertical plane, the second (6) and third (7) flange axis being symmetrical to a vertical plane through the first leg and in a ground view, a front view and a side view being arranged in acute angles to the first leg axis, turning of second and third legs (6, 7) thereby amending the angles of those legs in the ground view in relation to the plan of the first leg (2), all legs having the same length. With a fourth, shorter leg (8) on the first leg the distance between the pivot support axis and the first leg's resting point on the surface may be decreased substantially when second (6) and third (7) legs being adjusted in a small acute angle for shooting at ground level in a direction substantially in the longitudinal axis of the first leg (2).
Patent NO-903438-D0 (NO)
Inventor: MATSUO MASAAKI
IPC: A61K31/426
Filed: 1990-08-06
Abstract: A compound of the formula : <CHEM>  wherein  R<1> is hydrogen or acyl which may be substituted with halogen, R<2> is hydrogen, lower alkyl, hydroxy(lower)alkyl, halogen or carboxy,  A is -CH2-, -CO-, -C(=NOR<4>)- [wherein R<4> is lower alkyl, <CHEM>  [wherein m is 0, 1 or 2], and R<3> is aryl which may be substituted with halogen, hydroxy, lower alkoxy, nitro, amino or acylamino; or N-containing unsaturated heterocyclic group which may be substituted with lower alkyl, amino, hydroxy or halo(lower)alkyl,  and pharmaceutically acceptable salts thereof, processes for their preparation and pharmaceutical compositions comprising them as an active ingredient in admixture with pharmaceutically acceptable carriers.
Patent NO-914386-D0 (NO)
Inventor: DOMMER ARMIN
IPC: B29C65/50
Filed: 1991-11-08
Abstract: The invention relates to a device for welding a plastic hollow profile section (10), made up of profile sections (10.1,10.2), by pulling a heated wedge-shaped tool along separation gaps (12,13). The device is pulled through the cavity (11) of the plastic hollow profile section, heating bars (24.1,24.2) plastifying the gap walls (14-17) of the separation gaps and the plastic welding rods (20.1,20.2) required for welding. The plastified plastic welding rods are pressed by means of pressure-applying parts (25.1,25.2) into the plastified separation gaps when the device is continuously pulled through the plastic hollow profile section by means of a pulling means (29) and a speed-controllable geared motor.
Patent NO-923751-D0 (NO)
Inventor: HOPPE HARTMUT
IPC: B28D1/14
Filed: 1992-09-25
Abstract: A drilling device for producing drilled holes with an undercut has a drill bit having a drilling head, a depth stop, an enlargement provided between the the drilling head and the depth stop and acting as a swivel bearing, a suction bell rotatably mounted on the depth stop, a bearing washer, and a resilient, ring-shaped cushioning element provided on the depth stop. The cushioning element abuts against the bearing washer and is connected to the suction bell. The depth stop of the drill shank has a concavely curved end face and the bearing washer has a convexly curved sliding face which rests on the concavely curved end face of the depth stop.
Patent NO-924054-D0 (NO)
Inventor: ETCHEGOYEN DIDIER
IPC: E21B47/04
Filed: 1992-10-20
Abstract: PCT No. PCT/FR92/00179 Sec. 371 Date Dec. 14, 1992 Sec. 102(e) Date Dec. 14, 1992 PCT Filed Feb. 27, 1992 PCT Pub. No. WO92/15772 PCT Pub. Date Sep. 17, 1992.A device for measuring the movement of a drill pipe string, the end of which is held during drilling by an attachment assembly (12) movably along at least one guide rail (16), comprises a sensor assembly (38) mounted on the attachment assembly with a roller (42) designed to run on the rail as the attachment assembly moves.
Patent NO-924286-D0 (NO)
Inventor: CHEONG CATHERINE L
IPC: A61L15/22
Filed: 1992-11-06
Abstract: A wound dressing has a wound-contact layer formed from a polyurethane foam. The foam comprises one part by weight of the reaction product of an isocyanate-capped prepolymer with water (and optionally other hydroxy-functional compounds), and from 0.03 to 0.3 parts by weight of a natural or synthetic rubber. The isocyanate-capped prepolymer is preferably an isocyanate-capped ethyleneoxy/propyleneoxy copolymer, and the rubber is preferably an acrylic rubber.
Patent NO-924932-D0 (NO)
Inventor: BERGLUND SVANTE
IPC: F16K31/42
Filed: 1992-12-18
Abstract: A valve arrangement comprises a valve housing (4) which has a valve chamber (7, 13, 15) with an outlet (9, 10, 11, 12) and an inlet (16) which is adapted to be connected to a pressure-medium source (25), and a valve opening communicating with the valve chamber. A control valve (8, 22) is mounted on the valve housing (4) to close the outlet of the valve chamber when in closed position, and open this outlet when in open position. A main valve (14, 17) mounted on the valve housing (4) has, in the valve opening, a valve member (17) which is movable in response to the pressure in the valve chamber (7, 13, 15) between an outer closing position and an inner opening position. The inlet (16) of the valve chamber extends through the wall of the valve housing (4).
Patent NO-930174-D0 (NO)
Inventor: KALLAND TERJE
IPC: A61K47/48
Filed: 1993-01-19
Abstract: A soluble antibody conjugate comprising an antibody linked to a structure which is recognizable by T-cells and has the ability to direct T-cells to lyse the target cell, which is recognized by the antibody. The conjugate is characterized by the structure being a superantigen. One important mode is a method for the lysis of target cells, wherein the target cells are contacted with a target cell lysis effective amount of the conjugate. The method of lysis is part of a potent treatment regimen for cancer, autoimmunity, parasitic infestations and fungal, viral and bacterial infections. The specification also describes modes such as the synthesis of the conjugate and pharmaceutical compositions and their manufacture.
Patent NO-933570-D0 (NO)
Inventor: SOEDERBERG STAFFAN
IPC: B65B11/04
Filed: 1993-10-06
Abstract: PCT No. PCT/SE92/00230 Sec. 371 Date Oct. 25, 1993 Sec. 102(e) Date Oct. 25, 1993 PCT Filed Apr. 8, 1992 PCT Pub. No. WO92/07371 PCT Pub. Date Oct. 15, 1992.A method for packaging bales (1) with strips of plastic packaging film (9), in which a bale is rotated about a generally horizontal axis (3) and, when appropriate, about a generally vertical axis (6), and wherein film is taken from a film magazine (7) spaced from the bale and wrapped around the bale in successive turns while maintaining the film under tension, and wherein the film in each turn of film around the bale extends generally parallel with and transversely to the horizontal axis. The method is mainly characterized in the bale (1) is then wrapped with a further wrapping of film (9), and in that successive turns (9'') of this further wrapping cross-over those parts of the turns (9''') of the underlying film which extend generally parallel with the horizontal axis (3), in a manner to retain the underlying turns. This film material is held under tension while being applied. The invention also relates to an arrangement for carrying out the method, and to a bale.
Patent NO-941918-D0 (NO)
Inventor: MACOR JOHN EUGENE
IPC: A61K31/40
Filed: 1994-05-24
Abstract: PCT No. PCT/US92/08306 Sec. 371 Date May 20, 1994 Sec. 102(e) Date May 20, 1994 PCT Filed Oct. 6, 1992 PCT Pub. No. WO93/11106 PCT Pub. Date Jun. 10, 1993Compounds of the formula    <IMAGE>  I  wherein Z is   <IMAGE>   or   <IMAGE>   R1 is   <IMAGE> re each independently C, N, O, or S; wherein the remaining variables are defined in the specification, and the pharmaceutically acceptable salts thereof. These compounds are useful psychotherapeutics and are potent serotonin (5-HT1) agonists and may be used in the treatment of depression, anxiety, eating disorders, obesity, drug abuse, cluster headache, migraine, pain, chronic paroxysmal hemicrania and headache associated with vascular disorders, and other disorders arising from deficient serotonergic neurotransmission. The compounds can also be used as centrally acting antihypertensives and vasodilators.
Patent NO-942745-D0 (NO)
Inventor: JENSEN JOERN
IPC: B65D81/26
Filed: 1994-07-22
Abstract: A package tray serves to store liquid-containing food products, such as meat. The tray is made of e.g. sheeting and has a storage space which - seen in the normal position of rest of the tray - is downwardly defined by a base (11) and by upright side walls (10) along the sides. The base is formed with a plurality of ridges (17) having upwardly converging walls. In a zone of the base (11) between the side walls (10) and a predetermined central area (2) the height of the ridges (17) increases successively with the distance from the side walls (10), and the base (11) in this zone slopes downwards and inwards toward the central area (2). Exuding liquid, e.g. blood and tissue fluids from meat, runs to this central area (2) where it will be concealed to the buying public. The collected liquid in the central area (2) is kept spaced from the packaged food products by means of the ridges (17) in the area. Therefore, a packaged food product exuding liquid can be kept dry in the package tray even when stored for an extended period of time in e.g. a refrigerated display case, while the food product generally makes an aesthetic and hygenic impression on the customers.
Patent NO-950247-D0 (NO)
Inventor: GLASER WALTER
IPC: B66B5/16
Filed: 1995-01-23
Abstract: An elevator car braking system in which a pair of brake shoes engage and grip the hoisting ropes, part of the hoisting apparatus or the car guide rails when compressed springs, which are normally held in a compressed state by an electrically operable locking assembly, are released. The springs are compressible by a fluid operable piston and cylinder assembly. The springs move a cam follower, linked to one of the shoes, along cam surfaces shaped and disposed to cause the cam follower to move one brake shoe toward the other brake shoe. The locking assembly is responsive to car speed and/or movement of the car from a floor with its doors open. Switches operable by the cam follower control the car electrical controls so that movement of the car is prevented when the springs are not compressed and when there is excessive shoe wear.
Patent NO-964045-D0 (NO)
Inventor: NAKAE TAKAHITO
IPC: C07K5/078
Filed: 1996-09-26
Abstract: Sulfonamide derivatives of the formula (I) <CHEM> wherein R<1> is, inter alia, alkyl, alkoxy, hydroxy, keto, nitro, halogen, trihalomethyl, cyano, amidino and -COOR<7> (in which R<7> is hydrogen or alkyl),  n is an integer from 0 to 5; <CHEM>  is a carbocyclic ring or heterocyclic ring; <CHEM> in which R<2> and R<3> each is hydrogen, alkyl, alkoxy, halogen, trihalomethyl or phenyl, or  R<2> and R<3>, taken together, represent alkylidene, or <CHEM> in which R<2> and R<3>, taken together with the carbon atom to which they are attached represent cycloalkyl; R<4> is alkyl or alkoxy or two of R<4>, attached to the benzene nucleus at ortho positions relative to each other, taken together, represent alkylene; m is an integer from 0 to 4; and <CHEM> is optionally substituted amino or a nitrogen-containing ring, are described as new pharmaceutical compounds having inhibitory activity or elastase.